Therapeutic use of nucleotides in respiratory and ophthalmic diseases
- 1 January 2001
- journal article
- Published by Wiley in Drug Development Research
- Vol. 52 (1-2) , 196-201
- https://doi.org/10.1002/ddr.1116
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Constitutive Release of ATP and Evidence for Major Contribution of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase to Extracellular Nucleotide ConcentrationsJournal of Biological Chemistry, 2000
- The discovery and development of P2 receptor subtypesJournal of the Autonomic Nervous System, 2000
- Regulation of Ocular Mucin Secretion by P2Y2Nucleotide Receptors in Rabbit and Human ConjunctivaExperimental Eye Research, 1998
- CLINICAL IMPLICATIONS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MUTATIONSClinics in Chest Medicine, 1998
- Purinergic Signalling: Pathophysiological RolesThe Japanese Journal of Pharmacology, 1998
- Nucleotide-induced mucin release from primary hamster tracheal surface epithelial cells involves the P2u purinoceptorEuropean Respiratory Journal, 1996
- Human airway ion transport. Part one.American Journal of Respiratory and Critical Care Medicine, 1994
- Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.Proceedings of the National Academy of Sciences, 1994
- Effect of extracellular ATP and UTP on fluid transport by human nasal epithelial cells in culture.American Journal of Respiratory Cell and Molecular Biology, 1994
- Activation by Extracellular Nucleotides of Chloride Secretion in the Airway Epithelia of Patients with Cystic FibrosisNew England Journal of Medicine, 1991